Contact
searchSearch
HMP Global

*CANCELED* ACC.20 Together With World Congress of Cardiology (ACC.20/WCC)

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Bioresorbable Scaffolds
REVA Medical Announces Motiv Sirolimus-Eluting Bioresorbable Vascular Scaffold Live Case and Late-Breaking BTK Trial Results at VIVA26
10/08/2026
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
SAN DIEGO -- REVA Medical,...
10/08/2026
Cath Lab Digest
clinical trials
Cleerly's TRANSFORM Trial Expands Coronary CTA Access With Mobile CT Unit
10/08/2026
Operated with Clear Heart and Lung, the unit enables patients in communities without cardiac CT to join Cleerly's TRANSFORM, a trial testing whether treatment guided by coronary artery disease staging prevents heart attacks.
Operated with Clear Heart and Lung, the unit enables patients in communities without cardiac CT to join Cleerly's TRANSFORM, a trial testing whether treatment guided by coronary artery disease staging prevents heart attacks.
Operated with Clear Heart and...
10/08/2026
Cath Lab Digest
Lower-Extremity & Stroke Intervention
VIVA26: New Results From AGILITY, PERFORMANCE II, and XTRACT
10/07/2026
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Final late-breaking VIVA26...
10/07/2026
Cath Lab Digest
Peripheral Intervention
VIVA26: New Results From POWER PAD II, DISRUPT PAD BTK II, PROMISE III, ELEGANCE, and a TCOT Trial
10/07/2026
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Late-breaking VIVA26 studies...
10/07/2026
Cath Lab Digest
Pulmonary Embolism
VIVA26: New Results From HI-PEITHO, STORM-PE, and TRUST
10/07/2026
Three late-breaking VIVA26 studies reported new data on bleeding risk with ultrasound-facilitated catheter-directed thrombolysis, wearable-based functional recovery after intermediate-high-risk PE, and Laguna Thrombectomy System™ safety and...
Three late-breaking VIVA26 studies reported new data on bleeding risk with ultrasound-facilitated catheter-directed thrombolysis, wearable-based functional recovery after intermediate-high-risk PE, and Laguna Thrombectomy System™ safety and...
Three late-breaking VIVA26...
10/07/2026
Cath Lab Digest
Peripheral Intervention
VIVA26: New Results From SELUTION4SFA, SirPAD, SUCCESS PTA, CADET-PAD, Esprit BTK, and MOTIV BTK
10/07/2026
Six late-breaking VIVA26 studies reported new data on sirolimus-based balloon and resorbable scaffold therapies, as well as adjunctive pharmacologic treatment, for patients with PAD and chronic limb-threatening ischemia.
Six late-breaking VIVA26 studies reported new data on sirolimus-based balloon and resorbable scaffold therapies, as well as adjunctive pharmacologic treatment, for patients with PAD and chronic limb-threatening ischemia.
Six late-breaking VIVA26 studies...
10/07/2026
Cath Lab Digest
SCAD-ALIGN Trial
Mount Sinai Awarded $2 Million to Launch International Clinical Trial on Spontaneous Coronary Artery Dissection
10/07/2026
Mount Sinai will use the funding for a one-year feasibility phase of the United States portion of a major international clinical trial to determine whether aspirin alone or a more intensive combination of blood-thinning medications is better...
Mount Sinai will use the funding for a one-year feasibility phase of the United States portion of a major international clinical trial to determine whether aspirin alone or a more intensive combination of blood-thinning medications is better...
Mount Sinai will use the funding...
10/07/2026
Cath Lab Digest
American College of Cardiology (ACC)
Heart Disease Gaps Persist Despite Overall Declines
10/07/2026
Analysis shows racial, ethnic and place-based disparities in cardiovascular disease mortality in the U.S.
Analysis shows racial, ethnic and place-based disparities in cardiovascular disease mortality in the U.S.
Analysis shows racial, ethnic...
10/07/2026
Cath Lab Digest
iliac artery disease
VIVA 2026: BD's Revello Covered Stent Shows 97.2% Primary Patency in AGILITY Trial
10/07/2026
Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac...
Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac...
Data through 9 months of...
10/07/2026
Cath Lab Digest
Pulmonary Embolism
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
10/07/2026
Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and anticoagulation alone translate to patients’ everyday recovery.
Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and anticoagulation alone translate to patients’ everyday recovery.
Wearable-derived data provide...
10/07/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use